The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

Theratechnologies Inc closed at $0.73.

Over the last five days, shares have gained 19.67% and 102.78% year to date. Shares have outperformed the S&P TSX by 48.10% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward54.89×
  • Forward PEG249.49×
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.16
Updated at previous session's close. Delayed by at least 15 minutes.


Net Profit (TTM)

Although this company's net profit margin is negative, it is above the industry average and implies that Theratechnologies Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.13%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedAug 31, 201408/31/2014May 31, 201405/31/2014Feb 28, 201402/28/2014Nov 30, 201311/30/2013
Total other revenue--------
Total revenue0221
Gross profit0200
Total cost of revenue0021
Total operating expense4654
Selling / general / administrative2321
Research & development1212
Depreciation / amortization00----
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income-4-3-4-3
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Income before tax-41-4-3
Income after tax-41-4-3
Income tax, total0000
Net income-41-4-3
Total adjustments to net income--------
Net income before extra. items-41-4-3
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-41-4-3
Inc. avail. to common incl. extra. items-41-4-3
Diluted net income-41-4-3
Dilution adjustment0000
Diluted weighted average shares61616161
Diluted EPS excluding extraordinary itemsvalue per share-0.070.02-0.06-0.04
Dividends per sharevalue per share0.
Diluted normalized EPSvalue per share-0.070.02-0.06-0.05